TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
CompletedPhase 2

Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease

The objective of this study is to evaluate the safety and efficacy of ID1201 in patients with mild Alzheimer's disease

Busan, South Korea+19 moreView details
CompletedN/A

Reducing Behavioral and Psychological Symptoms of Dementia: Family Caregivers (Aim 1)

Persons with Alzheimer's Disease and Related Dementias (ADRD) account for 3.2 million hospital admissions per year and have over three times more hospitalizations than those without cognitive impairment, yet hospital caregivers (HCGs) are i

Glen Oaks, New York, United States+1 moreView details
CompletedN/A

Computerized Olfactory Test - Alzheimer Disease Mild Stage

This study evaluates the effectiveness of the smell tests that are used in early diagnosis of mild dementia.

Montreal, Quebec, CanadaView details
UnknownN/A

Study on the Effect of Transcranial Magnetic Stimulation in Mild to Moderate Alzheimer's Disease

The investigators will compare cognitition, mood (depression), ADL, and brain structural and functional MRI before and after 4-week transcranial magnetic stimulation in patients with mild to moderate Alzheimer's disease. The investigators a

Seoul, South KoreaView details
CompletedPhase 2

Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers

To study the safety of LY2062430 in patients with mild-to-moderate Alzheimer's disease and in healthy volunteers.

New Haven, Connecticut, United States+5 moreView details
CompletedPhase 2

Behavioral Sleep Intervention in Adult Family Homes

Sleep disturbances are widespread among demented residents of board and care homes and are a leading cause for transfer into nursing homes. This study is a randomized controlled clinical trial to evaluate the efficacy of a 4-week Sleep Educ

Seattle, Washington, United StatesView details
CompletedN/A

Erinacine A-enriched Hericium Erinaceus Mycelia for Improvement of Recognition, Vision, and Functional MRI Alterations

This study was designed as randomized double blind placebo study to investigate the efficacy of Erinacine A-enriched Hericium erinaceus mycelia for improvement of recognition, vision, and functional MRI alterations.

Taichung, TaiwanView details
RecruitingN/A

Adapting RDAD for DS

The goal of this clinical trial is to observe feasibility and initial efficacy of a remotely delivered exercise and dementia caregiving intervention in older adults with Down syndrome and their caregivers.

Kansas City, Kansas, United StatesView details
CompletedN/A

Impact of Musical Therapeutic Intervention on Depression in Dementia Patients and Caregiver Burden

This single-site interventional study evaluated the effects of receptive live music therapy on depression in patients with dementia and caregiver burden at the AMAVIDA Memory Care Unit in Fort Myers, Florida. Over two weeks, participants at

Fort Myers, Florida, United StatesView details
Completed

Prediction of Cognitive Decline by Neuroimaging Techniques and the Application in Diagnosis and Treatment of Preclinical AD

This study is affiliated to Sino Longitudinal Study on Cognitive Decline, SILCODE. To establish models of normal and pathological cognitive aging.To collect the longitudinal data of SCD population, to study the dynamic changes of brain netw

Beijing, Beijing Municipality, ChinaView details
Recruiting

Evaluation of a Neuropsychological Tool to Assess Temporal Processing Abilities in Alzheimer's Disease

Perceiving and representing the passage of time allows us to temporally organize perceptions and memories for the coordination of actions, planning, and the mobilization of cognitive processes toward a goal. This innovative project aims to

Caen, FranceView details
Recruiting

A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab

The primary purpose of this study is to investigate the characteristics of amyloid related imaging abnormalities (ARIA) and investigate the treatment continuation status (e.g., continuation, interruption) after the onset of ARIA in routine

Hiroshima, Japan+2 moreView details
RecruitingPhase 2

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

A phase 2, double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of Allopregnanolone as a regenerative therapeutic for Alzheimer's disease.

Scottsdale, Arizona, United States+9 moreView details
CompletedPhase 4

The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease

This study attempts to differentiate the clinical responses of Choline Acetyltransferase and Apolipoprotein Epsilon gene polymorphism to donepezil in Alzheimer's Disease patients.

Bundang, South Korea+14 moreView details
CompletedN/A

Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

The study tests the effect of the NeuroAD on Alzheimer patients' cognitive function. The NeuroAD uses non-invasive stimulation of both magnetic and cognitive training.

Sun City, Arizona, United States+9 moreView details
Completed

Observational Study on Costs and Caregiver Burden in Alzheimer's Disease

Objective of study is to assess the costs of care, objective and subjective caregiver burden and quality of life in relation to disease severity measured by cognitive function, ADL capabilities and presence of behavioral disturbances in Alz

Northport, Alabama, United States+81 moreView details
CompletedPhase 1

AZD3293 Thorough QT Study in Healthy Male Volunteers

A thorough QT study of AZD3293

Baltimore, Maryland, United StatesView details
CompletedPhase 1

Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients

To assess the pharmacodynamics (PD) of biomarkers amyloid beta peptide 40 and 42 (Ab40 and Ab42) in CSF, following single oral doses of GSI-953, an investigational drug, in healthy young subjects and patients with Alzheimer Disease (AD).

Glendale, California, United StatesView details
Not yet recruitingN/A

A Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients with Alzheimer's Disease.

The goal of this clinical trial is to learn if silkworm pupa powder works to improve the nutritional status of Alzheimer's disease patients. The main questions it aims to answer are: * Does silkworm pupa powder evaluate the effectiveness o

Hangzhou, Zhejiang, ChinaView details
Recruiting

Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)

This is a research study that aims to examine whether Veterans with mild Traumatic Brain Injuries are at risk for dementia by studying their memory, brain wave activity, brain structure and proteins that can be elevated after brain injury a

Boston, Massachusetts, United StatesView details
Load more trials